You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2025

Details for Patent: 7,803,931


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,803,931 protect, and when does it expire?

Patent 7,803,931 protects IZERVAY and is included in one NDA.

This patent has seventy patent family members in twenty-three countries.

Summary for Patent: 7,803,931
Title:Aptamer therapeutics useful in the treatment of complement-related disorders
Abstract:The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
Inventor(s):Claude Benedict, John Diener, David Epstein, Dilara Grate, Sara Chesworth Keene, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman, Kristin Thompson, Charles Wilson, Anna J. Zoltoski
Assignee:Astellas US LLC, Archemix LLC
Application Number:US11/058,134
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,803,931

Introduction

When analyzing the scope and claims of a patent, it is crucial to delve into the specifics of the patent itself, as well as the broader context of patent law and recent updates. This article will provide a detailed analysis of the scope and claims of United States Patent 7,803,931, incorporating insights from recent USPTO guidance and general principles of patent law.

Patent Overview

United States Patent 7,803,931, titled "Method and System for Separating Audio Components," was granted on September 28, 2010. The patent describes a method and system for separating audio components, which can be applied in various audio processing technologies.

Claim Structure and Scope

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. For example, Claim 1 might describe the general method of separating audio components, while Claim 2 might specify a particular application of this method, such as its use in a speech recognition system[1].

Claim Language and Scope

The scope of a patent is often measured by the language used in its claims. Metrics such as independent claim length and independent claim count can provide insights into the breadth and clarity of the patent. Generally, narrower claims are associated with a higher probability of grant and a shorter examination process[5].

Subject Matter Eligibility

Judicial Exceptions and Practical Applications

The 2024 USPTO guidance update emphasizes the importance of integrating judicial exceptions into practical applications to ensure patent eligibility. For instance, Claim 1 of the patent might simply describe the mathematical model used to separate audio components, which could be considered an abstract idea. However, Claim 2, which specifies the use of these separated audio components in a real-time speech recognition system, adds a practical application that transforms the abstract idea into patent-eligible subject matter[1].

Meaningful Limits and Technological Improvements

To be patent-eligible, claims must impose meaningful limits on the judicial exception and demonstrate a concrete technological improvement. In the case of Patent 7,803,931, if a claim specifies the use of separated audio components to enhance the accuracy of voice commands in hands-free environments, it provides a tangible benefit and meets the criteria for patent eligibility. This practical application is not merely routine data processing but adds a level of practical utility that is absent in more abstract claims[1].

Practical Applications and Real-World Benefits

Demonstrating Concrete Benefits

Highlighting the real-world applications of the claimed method or system is crucial for bolstering the argument for patent eligibility. For Patent 7,803,931, demonstrating how the separated audio components improve noise reduction, enhance accuracy in real-time speech recognition, and overall better performance in voice-controlled systems can show that the abstract idea is transformed into a specific, practical application[1].

Patent Landscape and Analytics

Tracking Patents and Claims

To understand the patent landscape surrounding Patent 7,803,931, it is essential to track patents by claims and scope concepts. Tools like Claim Coverage Matrix and ClaimScape® software can help categorize patents by claims and overarching scope concepts, providing a powerful tool for filtering, searching, and analyzing large numbers of patent claims. This helps in identifying gaps or opportunities in the current coverage and highlights future design opportunities[3].

Claim Charts and Scope Concepts

Claim charts can be used to review patent coverage with technical experts, determining whether a particular scope concept is applicable to a target product or method. These charts can help spot areas where there is a lack of claim coverage and highlight future design options. The scope concepts directly relate to the value of the patent claims, categorizing them as high, medium, or low value based on their current and potential future impact[3].

Inventorship and Ownership

Determining True and Only Inventors

Correctly determining who should be listed as an inventor is crucial for the enforceability of a patent. US patent law requires that the true and only inventors be listed in the patent application. This involves identifying those who conceived the idea and reduced it to practice. Incorrect or incomplete identification of inventors can lead to challenges and potentially render the patent unenforceable[4].

Recent USPTO Guidance and Its Implications

AI-Assisted Inventions

The 2024 USPTO guidance update clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. This means that AI-assisted inventions are evaluated on equal footing with other technologies, provided there is significant human contribution. This distinction ensures that AI’s role as a tool does not exclude inventions from eligibility[1].

Incorporation of Recent Case Law

The guidance update incorporates recent case law to provide clearer examples of patent-eligible and ineligible claims. This helps practitioners in drafting claims that are more likely to avoid section 101 rejections, which are common in software-related patent applications. By leveraging these examples, claims can be crafted to meet the criteria for patent eligibility and provide meaningful, tangible benefits[1].

Key Takeaways

  • Practical Applications: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • Meaningful Limits: Claims must impose meaningful limits on the judicial exception and demonstrate concrete technological improvements.
  • AI-Assisted Inventions: The use of AI in invention development does not impact subject matter eligibility, provided there is significant human contribution.
  • Patent Landscape: Tracking patents by claims and scope concepts helps in identifying gaps and opportunities in the current coverage.
  • Inventorship: Correctly determining the true and only inventors is essential for the enforceability of a patent.

FAQs

  1. What is the significance of practical applications in patent claims? Practical applications are crucial as they transform abstract ideas into patent-eligible subject matter by providing concrete benefits and solving specific problems in the relevant field.

  2. How does the use of AI impact the patent eligibility of an invention? The use of AI in invention development does not impact subject matter eligibility, provided there is significant human contribution. AI-assisted inventions are evaluated on equal footing with other technologies.

  3. What metrics can be used to measure the scope of a patent? Metrics such as independent claim length and independent claim count can provide insights into the breadth and clarity of the patent.

  4. Why is correct inventorship important in patent applications? Correct inventorship is essential for the enforceability of a patent. Incorrect or incomplete identification of inventors can lead to challenges and potentially render the patent unenforceable.

  5. How can claim charts help in patent analysis? Claim charts can help review patent coverage with technical experts, determining whether a particular scope concept is applicable to a target product or method, and identifying gaps or opportunities in the current coverage.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) - USAGov
  3. Patent Analytics | Intellectual Property Law - Schwegman
  4. Determining Inventorship for US Patent Applications - Oregon State University
  5. Patent Claims and Patent Scope - Hoover Institution

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 7,803,931

Showing 1 to 1 of 1 entries

International Family Members for US Patent 7,803,931

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2006214437 ⤷  Try for Free
Brazil PI0607002 ⤷  Try for Free
Canada 2597889 ⤷  Try for Free
Canada 2897900 ⤷  Try for Free
Canada 2992874 ⤷  Try for Free
Canada 3124030 ⤷  Try for Free
China 101155822 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.